Implandata Ophthalmic Products
IOP GmbH will initiate a paradigm chance in glaucoma therapy by its products for telemetric, 24 hour monitoring of intraocular pressure, allowing personalized patient management.
1.4 million series A financing of Implandata Ophthalmic Products GmbH: new kind of diagnosis tool for glaucoma therapy shortly before market launch
Hanover-based Implandata Ophthalmic Products GmbH distinguishes itself with innovative medical technology and will soon be executing the market launch of a promising system for monitoring the chronic eye disease of glaucoma. In a first closing round, Hannover Beteiligungsfonds, High-Tech Gründerfonds and a group of private investors are investing approx. €1.4 m in the young medical technology company. Implandata Ophthalmic Products GmbH has developed a new kind of system that makes it poss
High tech for eye patients: start-up team develops a new kind of diagnosis tool for glaucoma therapy
Recently established Implandata Ophthalmic Products GmbH, based in Hanover, has come up with a convincing, innovative piece of medical technology and will be launching a system for monitoring the chronic eye disease glaucoma. High-Tech Gründerfonds, hannover innovation fonds (hif), a Munich ophthalmologist as private investor as well as the two founders have invested about EUR 700,000 in this new technology business. Implandata Ophthalmic Products GmbH (IOP) has developed a new kind of syste
19. May 2010